Pharmalys Capacity Building Programme in Nigeria and Sierra Leone, September 2024 to February 2025

May 30, 2025 | Capacity building

Since September 2024, Pharmalys have conducted a series of capacity-building training sessions across four clinical research sites in Nigeria and Sierra Leone. Led by Mr. Assane Ndiaye and Mrs. Aissatou Ndour, the programme focused on equipping site staff with essential knowledge in Good Clinical Practice (GCP), Good Documentation Practice (GDP), and Data Integrity. This initiative forms a critical component of the preparatory efforts for the upcoming Phase 2b clinical trials on Lassa fever, funded by CEPI with trial-specific oversight by IAVI.

The training took place at Alex Ekwueme Federal University Teaching Hospital, Irrua Specialist Teaching Hospital, Kenema Government Hospital, and Owo Federal Hospital. Each session was conducted in a workshop format, blending in-person and online participation. On average, 70 participants attended each site, including principal investigators, sub-investigators, study coordinators, nurses, pharmacists, laboratory staff, data managers, institutional ethics committees members, and community engagement teams – all of whom play key roles in clinical research implementation.

Enhancing Research Competency Through Interactive Training

The programme was designed to strengthen the ability of site teams to conduct high-quality clinical trials while ensuring compliance with regulatory requirements and prioritising participant safety and data integrity. The training content was presented in person through face-to-face presentations, interactive discussions, and breakout sessions (group assignments), allowing participants to engage in case studies and apply theoretical knowledge to practical scenarios.

A key feature of the programme was the use of an online polling platform for knowledge assessments. This enabled real-time evaluation of participants’ understanding, encouraged active participation, installed healthy competition, and facilitated discussions on key concepts. Sessions were recorded for future reference, and participants who successfully completed the training received certificates of completion.

Participants’ Reflections on the Training

Feedback from participants highlighted the effectiveness and quality of the training. Over 63% strongly agreed that the purpose of the training was clearly communicated, and nearly 90% found the content easy to follow or agreed it was clear. Trainers Aissatou and Assane were particularly well-received, with two-thirds of respondents strongly agreeing that presenters responded effectively to questions. The atmosphere was described as dynamic and engaging, with participants appreciating the interactive format and collaborative learning environment. While some noted that the sessions were long, the suggestion was made to break the training into smaller modules for future editions to support better knowledge retention.

Building Sustainable Research Capacity in Africa

Pharmalys remains committed to supporting the development of local expertise in clinical research, ensuring that African researchers and institutions are equipped to conduct high-quality and impactful studies according to international standards. Initiatives such as this capacity-building programme are instrumental in creating a more inclusive and equitable clinical research landscape.

Watch the video below to hear Aissatou and Assane reflect on the training at Alex Ekwueme Federal University Teaching Hospital in Nigeria and share their key takeaways. This video was created by Alex Ekwueme Federal University Teaching Hospital (AEFUTHA).

 

Thank you to CEPI, IAVI, and all stakeholders involved in making this programme a success. Pharmalys looks forward to further collaborations to strengthen clinical research capacity and advance health research initiatives across the continent. #CountAfricaIn

For more information about capacity building at Pharmalys, click here or contact us.

Pharmalys corporate social responsibility commitments

Pharmalys corporate social responsibility commitments

Pharmalys’ approach to corporate social responsibility reflects its long-standing commitment to advancing clinical research while contributing to sustainable and inclusive healthcare systems, particularly across the African continent. Structured around three core...

A recap from the first Pharmalys Voice of 2026

A recap from the first Pharmalys Voice of 2026

On 26 March 26 2026, Pharmalys held its first Pharmalys Voice meeting of the year, bringing together colleagues from across the company for an engaging and interactive virtual session. With a mix of insightful presentations, lively discussions and moments of fun, the...

Women’s economic power benefits everyone

Women’s economic power benefits everyone

Gender equality is a core challenge to be met. More than 95% of women worldwide live in economies that do not provide full legal equality. Even in economies that have modernised their laws, women still face constraints that limit the work they can do, the businesses...

Microplastics and human health: A growing public health concern

Microplastics and human health: A growing public health concern

Developed following the 19th century Industrial Revolution, plastics are synthetic or semi-synthetic polymers, categorised according to the chemical composition of their primary polymer and any side chains. These include acrylics, polyesters, silicones, polyethylenes...

A successful GCLP Audit at Institut Pasteur de Dakar, Senegal

A successful GCLP Audit at Institut Pasteur de Dakar, Senegal

Jeanette Young’s unit at Pharmalys plays a crucial role in advancing global excellence in Good Clinical Laboratory Practice (GCLP) through the delivery of highly specialised ad hoc services, including tailored GCLP trainings and comprehensive gap analyses for...

Delivering excellence under complexity: Lessons learnt from Africa

Delivering excellence under complexity: Lessons learnt from Africa

Pharmalys is an international Clinical Research Organisation (CRO) with a diverse team distributed across Europe, Asia, North America and Africa. Within our global portfolio, we support the execution of numerous clinical trials (CTs) in Africa. Across these projects,...

Jeanette Young Shares GCLP Quality Insights with the TASK Team

Jeanette Young Shares GCLP Quality Insights with the TASK Team

On Friday 13 March 2026, Jeanette Young, Laboratory Solutions & GCLP Team Lead at Pharmalys, delivered an insightful and engaging presentation at TASK HQ  in South Africa. TASK is a global clinical research organisation with an in-house laboratory currently...